Researchers at the University of Pittsburgh School of Medicine have developed a new approach for tackling insulin resistance and type 2 diabetes by protecting beneficial immune cells in fat tissue.…
Breakthrough T1DSpotlight on OPF-310: A porcine-derived cell therapy in clinical trialsOne of our most promising avenues toward cures for type 1 diabetes is cell therapies. Learn more about one of…
Former Bristol Myers Squibb and Celgene executive to strengthen the Fund’s impact strategy and fuel transformative investments across innovative modalities BOSTON, Jan. 21, 2026 /PRNewswire/ — The T1D Fund: A Breakthrough…
NatureLab-made islet cell implants sail through diabetes trials, but are they ready yet?First-in-human studies provide hope that islet replacement therapies derived from stem cells will prove safe and effective in…
On January 6th, 2026, Encellin (California, Quebec) reported positive interim results of its Phase 1 clinical trial of encapsulated islets in people with type 1 diabetes (T1D), which is being carried…
A GROUNDBREAKING preclinical study has demonstrated that a chemotherapy-free, non-myeloablative conditioning regimen can induce durable mixed haematopoietic chimerism, restore immune tolerance, and completely reverse autoimmune type 1 diabetes in mouse models. The findings could pave…
LAS VEGAS, Dec. 16, 2025 /CNW/ — Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders,…
December 12, 2025 Add Us On GoogleAdd Science Cell Transplant Therapy Offers New Hope for Type 1 Diabetes Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type…
Stanford Medicine scientists report that giving mice both blood-forming stem cells and pancreatic islet cells from an immunologically mismatched donor either completely prevented or fully reversed Type 1 diabetes. In…
Scientists analyzing human and mouse pancreatic lymph nodes (PLNs) and spleens have identified a distinct subset of CD4 memory helper T cells associated with type 1 diabetes (T1D). Reported by…